Microbiota abnormalities in inflammatory airway diseases—Potential for therapy
ES Gollwitzer, BJ Marsland�- Pharmacology & therapeutics, 2014 - Elsevier
Increasingly the development of novel therapeutic strategies is taking into consideration the
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…
Microbiota abnormalities in inflammatory airway diseases—Potential for therapy
ES Gollwitzer, BJ Marsland�- Pharmacology and Therapeutics, 2014 - infona.pl
Increasingly the development of novel therapeutic strategies is taking into consideration the
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…
Microbiota abnormalities in inflammatory airway diseases-Potential for therapy.
ES Gollwitzer, BJ Marsland�- Pharmacology & therapeutics, 2014 - sonar.ch
English Increasingly the development of novel therapeutic strategies is taking into
consideration the contribution of the intestinal microbiota to health and disease. Dysbiosis of�…
consideration the contribution of the intestinal microbiota to health and disease. Dysbiosis of�…
Microbiota abnormalities in inflammatory airway diseases-Potential for therapy
ES Gollwitzer, BJ Marsland�- Pharmacology & Therapeutics, 2014 - research.monash.edu
Increasingly the development of novel therapeutic strategies is taking into consideration the
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…
[CITATION][C] Microbiota abnormalities in inflammatory airway diseases—Potential for therapy
ES Gollwitzer, BJ Marsland�- Pharmacology & Therapeutics, 2014 - cir.nii.ac.jp
Microbiota abnormalities in inflammatory airway diseases-Potential for therapy.
ES Gollwitzer, BJ Marsland�- Pharmacology & Therapeutics, 2013 - europepmc.org
Increasingly the development of novel therapeutic strategies is taking into consideration the
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…
Microbiota abnormalities in inflammatory airway diseases-Potential for therapy.
ES Gollwitzer, BJ Marsland�- Pharmacology & therapeutics, 2014 - folia.unifr.ch
English Increasingly the development of novel therapeutic strategies is taking into
consideration the contribution of the intestinal microbiota to health and disease. Dysbiosis of�…
consideration the contribution of the intestinal microbiota to health and disease. Dysbiosis of�…
[CITATION][C] Microbiota abnormalities in inflammatory airway diseases—Potential for therapy
ES GOLLWITZER…�- …�& therapeutics (Oxford), 2014 - pascal-francis.inist.fr
Microbiota abnormalities in inflammatory airway diseases — Potential for therapy CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced�…
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced�…
Microbiota abnormalities in inflammatory airway diseases-potential for therapy.
ES Gollwitzer, BJ Marsland - 2014 - cabidigitallibrary.org
Increasingly the development of novel therapeutic strategies is taking into consideration the
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…
Microbiota abnormalities in inflammatory airway diseases-Potential for therapy
ES Gollwitzer, BJ Marsland�- Pharmacology &�…, 2014 - pubmed.ncbi.nlm.nih.gov
Increasingly the development of novel therapeutic strategies is taking into consideration the
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…
contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial�…